Back to search

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction

Data up to Jan 2025

Published1998
Citations22
References24

Total Citations Per Year

Abstract

References (24)

A modified uronic acid carbazole reaction

1962 • 6,191 citations

Methods in Carbohydrate Chemistry

1972 • 5,061 citations

Implications of the three-dimensional structure of .alpha.1-antitrypsin for structure and function of serpins

1989 • 898 citations

Heparin Structure and Interactions with Basic Fibroblast Growth Factor

1996 • 789 citations

Glycosaminoglycans and the regulation of blood coagulation

1993 • 425 citations

The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics

1993 • 376 citations

Tissue Factor Pathway Inhibitor

1995 • 337 citations

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

1988 • 331 citations

TISSUE FACTOR PATHWAY INHIBITOR AND THE REVISED THEORY OF COAGULATION

1995 • 276 citations

Differences in the Interaction of Heparin with Arginine and Lysine and the Importance of these Basic Amino Acids in the Binding of Heparin to Acidic Fibroblast Growth Factor

1995 • 219 citations

Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol

1976 • 211 citations

Novel regio- and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence

1989 • 128 citations

The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.

1991 • 123 citations

Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin

1993 • 95 citations

Thermodynamics of Charged Oligopeptide-Heparin Interactions

1995 • 90 citations

Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa and tissue factor pathway inhibitor

1995 • 90 citations

The C-terminus of tissue factor pathway inhibitor (TFPI) is essential to its anticoagulant activity

1991 • 84 citations

Effect of Heparin on the Inhibition of Factor Xa by Tissue Factor Pathway Inhibitor: A Segment, Gly212-Phe243, of the Third Kunitz Domain Is a Heparin-Binding Site

1995 • 72 citations

A novel regioselective desulfation of polysaccharide sulfates: specific 6-O-desulfation with N,O-bis(trimethylsilyl)acetamide

1993 • 43 citations

Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae

1993 • 35 citations

Improved method for the immobilization of heparin

1987 • 31 citations

Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.

1996 • 27 citations

Antithrombin-mediated Inhibition of Factor Vlla-Tissue Factor Complex by the Synthetic Pentasaccharide Representing the Heparin Binding Site to Antithrombin

1996 • 22 citations

Tissue factor pathway inhibitor

1995 • 15 citations

Cited By (0)

Loading...
Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for… (1998) – Thrombosis Research | Metascience Observatory Explorer